Literature DB >> 2072155

The influence of volume on the tolerance of the brain to radiosurgery.

L B Marks1, D P Spencer.   

Abstract

Radiosurgery (delivery of a high dose of radiation to a small volume of the brain) is usually well tolerated since the volume of brain irradiated is small. Despite growing interest in radiosurgery, the influence of the volume of brain irradiated on the tolerance of the brain to radiation is not well understood. The results of six studies reporting clinically significant radiation reactions following radiosurgery for arteriovenous malformations are reviewed. In the combined series, 23 (9%) of 255 patients developed a clinically significant radiation reaction. The volume of brain irradiated and the dose delivered in each of these 23 patients are presented. The compiled data suggest that the previously presented guidelines may underestimate the risks of radiosurgery. Additional clinical and experimental data are needed to determine "safe" doses of radiation to be used during radiosurgery.

Entities:  

Mesh:

Year:  1991        PMID: 2072155     DOI: 10.3171/jns.1991.75.2.0177

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  13 in total

Review 1.  New prospects for management and treatment of inoperable and recurrent skull base meningiomas.

Authors:  Mahlon D Johnson; Burak Sade; Michael T Milano; Joung H Lee; Steven A Toms
Journal:  J Neurooncol       Date:  2007-07-12       Impact factor: 4.130

2.  Permanent low-activity iodine-125 implants for cerebral metastases.

Authors:  M Schulder; P M Black; D C Shrieve; E Alexander; J S Loeffler
Journal:  J Neurooncol       Date:  1997-07       Impact factor: 4.130

3.  Glioblastoma revisited: do clinical observations match basic science theory? Radiosurgery: clinical observations.

Authors:  E Alexander
Journal:  J Neurooncol       Date:  1993-08       Impact factor: 4.130

4.  Long-term outcome of moderate hypofractionated stereotactic radiotherapy for meningiomas.

Authors:  Ernesto Maranzano; Lorena Draghini; Michelina Casale; Fabio Arcidiacono; Paola Anselmo; Fabio Trippa; Cesare Giorgi
Journal:  Strahlenther Onkol       Date:  2015-10-21       Impact factor: 3.621

Review 5.  Recent trends in the radiotherapy of pediatric gliomas.

Authors:  N J Tarbell; J S Loeffler
Journal:  J Neurooncol       Date:  1996 May-Jun       Impact factor: 4.130

6.  Phase I three-dimensional conformal radiation dose escalation study in newly diagnosed glioblastoma: Radiation Therapy Oncology Group Trial 98-03.

Authors:  Christina Tsien; Jennifer Moughan; Jeff M Michalski; Mark R Gilbert; James Purdy; Joseph Simpson; John J Kresel; Walter J Curran; Aidnag Diaz; Minesh P Mehta
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-08-23       Impact factor: 7.038

7.  Dosimetric comparison of Gamma Knife® IconTM and linear accelerator-based fractionated stereotactic radiotherapy (FSRT) plans for the re-irradiation of large (>14 cm3) recurrent glioblastomas.

Authors:  Matthew E Schelin; Haisong Liu; Ayesha Ali; Wenyin Shi; Yan Yu; Karen E Mooney
Journal:  J Radiosurg SBRT       Date:  2021

8.  Outcome of cerebral arteriovenous malformations after linear accelerator reirradiation.

Authors:  Paulo L Moraes; Rodrigo S Dias; Eduardo Weltman; Adelmo J Giordani; Salomon Benabou; Helena R C Segreto; Roberto A Segreto
Journal:  Surg Neurol Int       Date:  2015-06-04

Review 9.  Single- and Multifraction Stereotactic Radiosurgery Dose/Volume Tolerances of the Brain.

Authors:  Michael T Milano; Jimm Grimm; Andrzej Niemierko; Scott G Soltys; Vitali Moiseenko; Kristin J Redmond; Ellen Yorke; Arjun Sahgal; Jinyu Xue; Anand Mahadevan; Alexander Muacevic; Lawrence B Marks; Lawrence R Kleinberg
Journal:  Int J Radiat Oncol Biol Phys       Date:  2020-09-11       Impact factor: 8.013

10.  Gamma knife radiosurgery of craniopharyngioma: results of 30 cases treated at Nagoya Radiosurgery Center.

Authors:  Tatsuya Kobayashi; Takahiko Tsugawa; Manabu Hatano; Chisa Hashizume; Yoshimasa Mori; Yuta Shibamoto
Journal:  Nagoya J Med Sci       Date:  2015-08       Impact factor: 1.131

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.